OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Preventing Anthracycline-Associated Heart Failure: What Is the Role of Dexrazoxane?
Haoyi Zheng, Huichun Zhan
JACC CardioOncology (2024) Vol. 6, Iss. 2, pp. 318-321
Open Access | Times Cited: 8
Haoyi Zheng, Huichun Zhan
JACC CardioOncology (2024) Vol. 6, Iss. 2, pp. 318-321
Open Access | Times Cited: 8
Showing 8 citing articles:
Rationale and design of RESILIENCE : A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity
Andrea Moreno‐Arciniegas, Alberto López García, Malte Kelm, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 10, pp. 2213-2222
Open Access | Times Cited: 5
Andrea Moreno‐Arciniegas, Alberto López García, Malte Kelm, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 10, pp. 2213-2222
Open Access | Times Cited: 5
Trastuzumab-Induced Cardiotoxicity: When and How Much Should We Worry?
Haoyi Zheng, Syed Mahmood, Omar Khalique, et al.
JCO Oncology Practice (2024) Vol. 20, Iss. 8, pp. 1055-1063
Closed Access | Times Cited: 4
Haoyi Zheng, Syed Mahmood, Omar Khalique, et al.
JCO Oncology Practice (2024) Vol. 20, Iss. 8, pp. 1055-1063
Closed Access | Times Cited: 4
Exercise training partly ameliorates cardiac dysfunction in mice during doxorubicin treatment of breast cancer
Tytti‐Maria Uurasmaa, Pauline Bourdin, Wail Nammas, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Tytti‐Maria Uurasmaa, Pauline Bourdin, Wail Nammas, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Anthracycline-induced cardiomyopathy: risk prediction, prevention and treatment
Iacopo Fabiani, Michela Chianca, Carlo M. Cipolla, et al.
Nature Reviews Cardiology (2025)
Closed Access
Iacopo Fabiani, Michela Chianca, Carlo M. Cipolla, et al.
Nature Reviews Cardiology (2025)
Closed Access
Anthracycline-induced cardiotoxicity: emerging mechanisms and therapies
Guanjing Ling, Fei Ge, Weili Li, et al.
Medicine Plus (2025), pp. 100074-100074
Open Access
Guanjing Ling, Fei Ge, Weili Li, et al.
Medicine Plus (2025), pp. 100074-100074
Open Access
Dexrazoxane makes doxorubicin-induced heart failure a rare event in sarcoma patients receiving high cumulative doses
Haoyi Zheng, Huichun Zhan
Cardio-Oncology (2025) Vol. 11, Iss. 1
Open Access
Haoyi Zheng, Huichun Zhan
Cardio-Oncology (2025) Vol. 11, Iss. 1
Open Access
PCSK9 Inhibitors and Anthracyclines: The Future of Cardioprotection in Cardio-Oncology
Matthew Leonard Repp, Mark D. Edwards, Christopher S. Burch, et al.
Hearts (2024) Vol. 5, Iss. 3, pp. 375-388
Open Access | Times Cited: 1
Matthew Leonard Repp, Mark D. Edwards, Christopher S. Burch, et al.
Hearts (2024) Vol. 5, Iss. 3, pp. 375-388
Open Access | Times Cited: 1
Safety Evaluation of the Combination with Dexrazoxane and Anthracyclines: A Disproportionality Analysis Based on the Food and Drug Administration Adverse Event Reporting System Database
Danyi Liu, Junting Liu, Rui Xiao, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1739-1739
Open Access
Danyi Liu, Junting Liu, Rui Xiao, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1739-1739
Open Access
